Zakłady Naukowe WIHE

Dział Wsparcia Badań

Konkursy Krajowe

Ostatnio dodane

Konkursy krajowe 2019 r. (plik Excel)

Ostatnio dodane

SC1-BHC-01-2019: Understanding causative mechanisms in co ...

Konkursy Międzynarodowe

Konkurs	Opis	Termin składania wniosków	Wysokość dofinansowania
Horyzont 2020 (H 2020)
TOPIC : SCI-BHC-03-2018: Exploiting research outcomes and application potential of the human microbiome for personalised prediction, prevention and treatment of disease	Scope The aim is to achieve understanding of balanced states of health and on that basis to deliver personalised approaches and clinical tools for predicting and preventing diseases. Proposals should integrate and use high quality microbiome, metabolome and other -omics data produced by large scale international initiatives. They should combine and expand these data with approaches including disease-oriented functional analysis, endogenous and exogenous factors, innovative imaging, functional, structural and lifestyle, ageing, dietary data, environmental data, mental disorders and/or any other comorbidity.	18 April 2018 17:00:00	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-03-2018.html

TOPIC : SC1-BHC-04-2018: Rare Disease European Joint Programme Cofund	Scope The overall objective is to implement a European Joint Programme (EJP) Cofund for Rare Diseases which would create a research and innovation pipeline "from bench to bedside" ensuring rapid translation of research results into clinical applications and uptake in healthcare for the benefit of patients. The specific objectives of the EJP Cofund are to improve integration, efficacy, production and social impact of research on rare diseases through the development, demonstration and promotion of sharing of research and clinical data, materials, processes, knowledge and know-how, and to implement and further develop an efficient model of financial support for research on rare diseases including basic, clinical, epidemiological, social and health service research.	18 April 2018 17:00:00	COFUND-EJP COFUND (European Joint Programme)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-04-2018.html

TOPIC : SC1-BHC-05-2018: International flagship collaboration with Canada for human data storage, integration and sharing to enable personalised medicine approaches	Scope To build a collaboration of stakeholders in Europe and Canada in the domain of repositories storing and sharing human –omics data that will create a framework for long-term cooperation. In order to do so, this programme aims to enhance and standardise data deposition, curation and exchange procedures thus ensuring better data reuse and increased benefit to the scientific communities worldwide. The selected projects should build on the data quality metrics, standards and access policies developed by major international initiatives	18 April 2018 17:00:00	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-05-2018.html

TOPIC : SC1-BHC-09-2018: Innovation platforms for advanced therapies of the future	Scope Building on European strengths and using the definition set out in Regulation (EC) 1394/2007[1], projects should create knowledge, testing and exploitation platforms around innovative concepts for advanced therapy development. Platforms should comprise the components and expertise necessary to create a solid foundation on which to build possible new therapeutic approaches and/or aim to overcome particular development bottlenecks. Possible components could include studying the basic biology of the potential therapy and investigating its mode of action, proof of concept (in vitro, in animal models – where necessary - or first-in–man studies); safety, efficacy, characterisation, refinement and manufacturing of the product could be considered	18 April 2018 17:00:00	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-09-2018.html

TOPIC : SC1-BHC-15-2018: New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)	Scope The topic bridges the gap between preclinical and early clinical development of drugs and/or vaccines against neglected bacterial and parasitic diseases[1]. Therefore, the proposed actions should focus on late preclinical (e.g. validation in animal models, toxicology, Good Manufacturing Practices (GMP) production, preparation of Investigational Medicinal Product Dossier) and early clinical (up to phase 1) development of already existing lead drug and vaccine candidates.	06 February 2018 17:00 04 September 2018 17:00	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-15-2018.html

TOPIC : SC1-BHC-16-2018: Global Alliance for Chronic Diseases (GACD) - Scaling-up of evidence-based health interventions at population level for the prevention and management of hypertension and/or diabetes	Scope Proposals must focus on the scale-up of interventions at population level for hypertension and/or diabetes prevention and/or management in LMIC, and/or in vulnerable populations in HIC. Proposals addressing comorbidities with either hypertension or diabetes, including between them, are encouraged. Proposals must align with commitments or planned commitments at a regional or country level to implement evidence-based interventions (including evidence of cost-effectiveness and affordability) across health or other sectors.	18 April 2018 17:00	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-16-2018.html

TOPIC : SC1-BHC-18-2018: Translational collaborative cancer research between Europe and the Community of Latin American and Caribbean States (CELAC)	Scope Proposals must focus on translational and multidisciplinary research to identify specific patient groups in view of improving one or more of the following aspects: screening, early detection, diagnosis, and/or prognosis. Proposals must build on the diverse genetic backgrounds, risk factors, cancer incidence, geographical environment, and/or different healthcare models (including social care and volunteers) in European and CELAC countries. Proposals may integrate molecular, behavioural, nutritional, clinical, social and environmental epidemiology data from cohorts; registries; biobanks; repositories; research infrastructures.	18 April 2018 17:00	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-18-2018.html

TOPIC : SC1-BHC-21-2018: Research on HIV, tuberculosis (TB) and/or hepatitis C (HCV) in patients with mono-, co-infections and/or comorbidities in the context of fostering collaboration with the Russian Federation	Scope Proposals should address one or more of the following subtopics: TB: To investigate biomarkers or new diagnostic tests for early screening of TB risk groups for TB infection and identification of antimicrobial drug resistance. HIV: To investigate the susceptibility to HIV and/or disease progression rate after infection, including various HIV subtypes and/or transmission clusters, and/or the development of adverse effects during antiretroviral therapy and concomitant diseases (comorbidities and/or co-infections, including with tuberculosis). HCV: To evaluate the genetic determinants of the virus and the host, and comorbid conditions that can be involved in disease progression and create the basis for the development of future HCV treatment strategies.	18 April 2018 17:00	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-21-2018.html

TOPIC : SC1-BHC-23-2018: Novel patient-centred approaches for survivorship, palliation and/or end-of-life care	Scope Proposals should demonstrate, the effectiveness and cost-effectiveness of new, improved or specifically adapted pharmacological and/or non-pharmacological interventions to either relieve symptoms (e.g. pain) and suffering caused by life-threatening non-communicable diseases (including disabilities), or serious late and long-term side effects of disease treatments in patients and survivors, or symptoms that occur at the end of life. Randomised clinical trials or observational studies of new or improved patient and/or family centred interventions, targeting children and/or adults, should be considered for this topic.	18 April 2018 17:00	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-23-2018.html

TOPIC : SC1-BHC-26-2018: Novel patient-centred approaches for survivorship, palliation and/or end-of-life care	Scope Proposals should develop new or improved methodological approaches and frameworks, and foster methodological consensus-building, to address all of the following areas: Specific types or groups of health technologies Selected therapeutic areas Use of real-world data Implementation	18 April 2018 17:00	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-26-2018.html

TOPIC : SC1-BHC-27-2018: New testing and screening methods to identify endocrine disrupting chemical	Scope New and improved approaches are needed to increase the quality, the efficiency and the effectiveness of existing methods to meet demanding and evolving regulatory requirements worldwide. In consultation with relevant regulatory bodies, research should improve and harmonise screening and testing protocols/strategies and hazard/risk assessments by developing better and faster tools, test methods or models, including in vitro and in vivo tests, high-throughput and in silico methods (e.g. QSAR), potentially combined with research on adverse outcomes pathways. For in vitro tests, appropriate coupling of their results to human health effects should be ensured. Information is also needed as regards how epidemiological and field monitoring data.	18 April 2018 17:00	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-27-2018.html

TOPIC : SC1-HCO-01-2018-2019-2020: Actions in support of the International Consortium for Personalised Medicine	Scope Each action should focus on one of the following fields: International aspect: The action should focus on building links with third countries by analysing the potential and advantages of collaboration in personalised medicine (PM) Regional aspect: The action should establish and support networking between regions and interregional cooperation in different European countries, in particular linking remote or sparsely populated regions with regions harbouring critical mass of medical and PM expertise while taking into account broader socio-economic and cultural aspects Healthcare- and pharma-economic models for personalised medicine, interlinking European public health approaches with medical practice and financing Standardisation for clinical study design. Establishment of innovative clinical trial design methodology for PM, including guidelines for research and reflection papers.	I). single-stage ogłoszony 07 November 2017 do 18 April 2018 17:00 II). single-stage ogłoszony 26 July 2018 do 16 April 2019 17:00	Coordination/ Support Action (CSA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-01-2018-2019-2020.html

TOPIC : SC1-HCO-02-2018: Data integration and data-driven in-silico models for enabling personalised medicine - a European standardization framework	Scope The proposal should establish a forum for in-silico methodologies applied in translational and clinical research, where different transnational initiatives should meet and debate on their standardisation strategies.	18 April 2018 17:00	CSA Coordination and support action
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-02-2018.html

TOPIC : SC1-HCO-04-2018: ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)	Scope Proposals should pool the necessary financial resources from participating national or regional research programmes in the area of neurodegenerative diseases research by implementing a transnational joint call for proposals resulting in grants to third parties with EU co-funding, with a view to scale-up the implementation of the JPND Research Strategy. Proposers are requested to also implement other joint activities, including training and additional joint calls without EU co-funding.	18 April 2018 17:00	ERA-NET Cofund
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-04-2018.html

TOPIC : SC1-HCO-05-2018: Strengthening regulatory sciences and supporting regulatory scientific advice	Scope Proposals should: establish, regularly update and disseminate a comprehensive inventory of existing support activities for regulatory Scientific Advice and Protocol Assistance in Europe such as the Innovation Task Force analyse the effectiveness of existing support activities and develop a common strategy for training programmes to strengthen regulatory sciences and improve support for successful outcomes from regulatory Scientific Advice and Protocol Assistance based on identified best practices support and/or advice for the delivery of corresponding pilot training programmes in an efficient and collaborative manner assess the need for and possibly propose additional mechanisms sustainably supporting academic groups in regulatory Scientific Advice and Protocol Assistance	18 April 2018 17:00	CSA Coordination and support action
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-05-2018.html

TOPIC : SC1-HCO-06-2018: Establishment of an International Network of Social Sciences Research Centres to help address governance and other challenges in the preparedness for and the response to infectious threats	Scope The scope of this Coordination and Support Action (CSA) is to: Initiate, in an organised and coordinated manner, the International Network of Social Sciences Research Expertise, addressing governance challenges, engage with stakeholders on behalf of network members, and work with research funding agencies to grow the network to an effective, internationally representative scale. The proposed network would have the following main objectives : Strengthen research capacity and catalyse social sciences researchers to generate and apply new knowledge about effective governance arrangements for infectious disease preparedness Foster cross-region and global research collaborations to better connect researchers Facilitate ongoing engagement between researchers and global policymakers Inform and enable better preparedness and response efforts through the application of knowledge, sharing of lessons learned, and creation of improved governance arrangements.	do 18 April 2018 17:00	CSA Coordination and support action
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-06-2018.html

TOPIC : SC1-HCO-09-2018: Building international efforts on population and patient cohorts	Scope Building on existing cohorts (grup) and in close alliance with relevant research infrastructures, proposals should establish a strategy for the development of the next generation of integrated cohorts, including: Map the cohort landscape in Europe and large international initiatives. Identify best strategies for cohorts' integration, taking into account relevant ethical issues. Promote the harmonisation of past and future data collection Foster the inclusion of data emerging from new technologies. Promote best practises to optimise access to existing and future cohorts.	do 18 April 2018 17:00	CSA Coordination and support action
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-09-2018.html

TOPIC : SC1-HCO-10-2018: Coordinating European brain research and developing global initiatives	Scope Identify areas of neurosciences where the need for enhanced coordination of research communities into active clusters is particularly acute. Accelerate exchange between researchers in different European research initiatives to promote cooperation and to minimise fragmentation and duplication. Support the emergence of these clusters, facilitate links with research infrastructures and other major initiatives, in coordination with European Commission services, with the aim of sharing data and enhancing the exploitation of results, fostering new collaborations and identifying future research objectives.	do 18 April 2018 17:00	CSA Coordination and support action
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-10-2018.html

TOPIC : SC1-HCO-11-2018: Strategic collaboration in health research and innovation between EU and China	Scope European and Chinese policy makers, programme owners and funders, with the goal: To develop a sustainable platform between EU and China that will facilitate a constant dialogue on addressing common health R&I challenges.	do 18 April 2018 17:00	CSA Coordination and support action
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-11-2018.html

TOPIC : SC1-HCO-12-2018: Innovation in healthcare - a CSA towards using pre-commercial procurement and public procurement of innovative solutions in healthcare systems	Scope The objective of this coordination and support action (CSA) is to create a Europe-wide consortium of healthcare providers and public procurers in the health and social care sector that define together unmet procurement needs to implement innovative solutions in healthcare.	do 18 April 2018 17:00	CSA Coordination and support action
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-hco-12-2018.html

TOPIC : SC1-BHC-01-2019: Understanding causative mechanisms in co- and multimorbidities	Scope Proposals should identify and validate causative mechanisms (e.g. molecular, genetic, correlative, drug-drug interaction) combining mental and physical disorders through the integration of basic, pre-clinical and/or clinical research..	Planned opening: 26 July 2018 Deadline: 02 October 2018 2nd stage Deadline: 16 April 2019	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-01-2019.html

TOPIC : SC1-BHC-02-2019: Systems approaches for the discovery of combinatorial therapies for complex disorders	Scope Research should aim to understand at systems level the pathophysiology of a disorder in groups of patients responding well or poorly to particular therapies and further develop combinatorial therapies tailored to the needs of individuals or stratified patient groups.	Planned opening: 26 July 2018 Deadline: 02 October 2018 2nd stage Deadline: 16 April 2019	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-02-2019.html

TOPIC : SC1-BHC-07-2019: Regenerative medicine: from new insights to new applications	Scope Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function. Projects should focus on innovative translational research to develop regenerative processes towards the ultimate clinical goal of addressing unmet clinical needs of large patient groups. Proposals should be based on new approaches such as genome editing or gene therapy, transdifferentiation or in vivo reprogramming, cell therapy and transplantation, 3D bioprinting, organoids or use of combined products (non-exhaustive list for illustrative purposes only). In all cases, proposals should explain in what way their approach is regenerative. Research on improved methods of tissue and organ transplantation is included on the condition that there is a clear regenerative step in the process. The project may focus on any step(s) on the innovation chain, from early testing and characterization of regenerative mechanisms to preclinical research, proof of concept or clinical trial. Sex and gender differences should be investigated, where relevant. Projects should include a section on the proposed therapy's exploitation potential, regulatory and commercialisation strategy and how it would be made available and delivered to patients.	Planned opening: 26 July 2018 Deadline: 16 April 2019	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-07-2019.html

TOPIC : SC1-BHC-10-2019: Innovation Procurement: Next generation sequencing (NGS) for routine diagnosis	Scope The objective is to implement NGS in routine diagnostics for personalised medicine and scale up demand-driven innovation for healthcare systems. This includes organisational, economical, technical and clinical aspects. It should lead to NGS tests, clinically validated procedures (including sex analysis), quality assurance schemes, tools and methods for data collection, management, analysis and interpretation, with a view to assist clinical decision-making and foster medical research and innovation.	Planned opening: 26 July 2018 Deadline: 16 April 2019
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-10-2019.html

TOPIC : SC1-BHC-13-2019: Mining big data for early detection of infectious disease threats driven by climate change and other factors	Scope It is expected that proposals develop: the technology to allow the pooling, access, analysis and sharing of relevant data, including next generation sequencing the innovative bio-informatics and modelling methodologies that enable risk modelling and mapping; and the analytical tools for early warning, risk assessment and monitoring of (re-)emerging infectious disease threats.	Planned opening: 26 July 2018 Deadline: 16 April 2019	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-13-2019.html

TOPIC : SC1-BHC-14-2019: Stratified host-directed approaches to improve prevention, treatment and/or cure of infectious diseases	Scope Proposals should test emerging concepts in drug and/or vaccine development in order to address the problem of antimicrobial drug resistance and to optimize therapeutic, curative or preventive measures against infectious diseases of major concern for Europe. Proposals should capitalize on knowledge of the role of host factors, immune-modulators or of host-pathogen interactions influencing disease outcome that can be utilized to strengthen the response to treatment or prevention measures.	Planned opening: 26 July 2018 Deadline: 02 October 2018 2nd stage Deadline: 16 April 2019	Research and Innovation action (RIA)
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-14-2019.html

TOPIC : SC1-BHC-19-2019: Implementation research for maternal and child health	Scope Proposals should focus on implementation research for improving maternal and child health with a focus on the first '1000 days' from pregnancy until two years of age This research can take place in either high income countries or low and middle income countries, or in a combination thereof. The implementation research in the first 1000 days may cover: new or improved health service delivery interventions that strengthen maternal and child health; and/or the scaling up and/or adapting of existing evidence-based interventions to new contexts.	Planned opening: 26 July 2018 Deadline: 02 October 2018 2nd stage Deadline: 16 April 2019
Więcej informacji:	https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/sc1-bhc-19-2019.html